JP2005509662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005509662A5 JP2005509662A5 JP2003545302A JP2003545302A JP2005509662A5 JP 2005509662 A5 JP2005509662 A5 JP 2005509662A5 JP 2003545302 A JP2003545302 A JP 2003545302A JP 2003545302 A JP2003545302 A JP 2003545302A JP 2005509662 A5 JP2005509662 A5 JP 2005509662A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- compound
- formula
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 67
- 150000001875 compounds Chemical class 0.000 claims 23
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 239000003814 drug Substances 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 11
- 208000027866 inflammatory disease Diseases 0.000 claims 10
- 239000002537 cosmetic Substances 0.000 claims 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 230000005855 radiation Effects 0.000 claims 6
- 239000007788 liquid Substances 0.000 claims 5
- 230000037075 skin appearance Effects 0.000 claims 5
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 5
- DUVJMSPTZMCSTQ-UHFFFAOYSA-N 2-ethoxybenzaldehyde Chemical compound CCOC1=CC=CC=C1C=O DUVJMSPTZMCSTQ-UHFFFAOYSA-N 0.000 claims 4
- XHWMNHADTZZHGI-UHFFFAOYSA-N 4-butoxybenzaldehyde Chemical compound CCCCOC1=CC=C(C=O)C=C1 XHWMNHADTZZHGI-UHFFFAOYSA-N 0.000 claims 4
- JRHHJNMASOIRDS-UHFFFAOYSA-N 4-ethoxybenzaldehyde Chemical compound CCOC1=CC=C(C=O)C=C1 JRHHJNMASOIRDS-UHFFFAOYSA-N 0.000 claims 4
- GWXUVWKBVROFDM-UHFFFAOYSA-N 4-hexoxybenzaldehyde Chemical compound CCCCCCOC1=CC=C(C=O)C=C1 GWXUVWKBVROFDM-UHFFFAOYSA-N 0.000 claims 4
- YAPVGSXODFOBBR-UHFFFAOYSA-N 4-pentoxybenzaldehyde Chemical compound CCCCCOC1=CC=C(C=O)C=C1 YAPVGSXODFOBBR-UHFFFAOYSA-N 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 4
- FGXZWMCBNMMYPL-UHFFFAOYSA-N 4-propoxybenzaldehyde Chemical compound CCCOC1=CC=C(C=O)C=C1 FGXZWMCBNMMYPL-UHFFFAOYSA-N 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 206010042496 Sunburn Diseases 0.000 claims 3
- 239000006071 cream Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 208000017520 skin disease Diseases 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000002993 cycloalkylene group Chemical group 0.000 claims 2
- 230000004968 inflammatory condition Effects 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical compound COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 claims 1
- WDANSDASCKBVKH-UHFFFAOYSA-N 4-propan-2-yloxybenzaldehyde Chemical compound CC(C)OC1=CC=C(C=O)C=C1 WDANSDASCKBVKH-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33227701P | 2001-11-16 | 2001-11-16 | |
| US34604902P | 2002-01-04 | 2002-01-04 | |
| US36856502P | 2002-04-01 | 2002-04-01 | |
| US36851802P | 2002-04-01 | 2002-04-01 | |
| US38469002P | 2002-05-30 | 2002-05-30 | |
| US38458902P | 2002-05-30 | 2002-05-30 | |
| PCT/US2002/021844 WO2003043621A1 (en) | 2001-11-16 | 2002-08-16 | Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009282263A Division JP2010059203A (ja) | 2001-11-16 | 2009-12-11 | オキシ基保有芳香族アルデヒドを含有する薬学的組成物および美容用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005509662A JP2005509662A (ja) | 2005-04-14 |
| JP2005509662A5 true JP2005509662A5 (enExample) | 2005-12-22 |
| JP4587669B2 JP4587669B2 (ja) | 2010-11-24 |
Family
ID=32660228
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003545302A Expired - Lifetime JP4587669B2 (ja) | 2001-11-16 | 2002-08-16 | オキシ基保有芳香族アルデヒドを含有する薬学的組成物および美容用組成物 |
| JP2009282263A Withdrawn JP2010059203A (ja) | 2001-11-16 | 2009-12-11 | オキシ基保有芳香族アルデヒドを含有する薬学的組成物および美容用組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009282263A Withdrawn JP2010059203A (ja) | 2001-11-16 | 2009-12-11 | オキシ基保有芳香族アルデヒドを含有する薬学的組成物および美容用組成物 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1443915B1 (enExample) |
| JP (2) | JP4587669B2 (enExample) |
| KR (1) | KR100887601B1 (enExample) |
| CN (2) | CN102973417A (enExample) |
| AT (1) | ATE330591T1 (enExample) |
| AU (1) | AU2002326363B2 (enExample) |
| BR (1) | BR0214208A (enExample) |
| CA (1) | CA2464867C (enExample) |
| DE (1) | DE60212683T2 (enExample) |
| DK (1) | DK1443915T3 (enExample) |
| EA (1) | EA009281B1 (enExample) |
| ES (1) | ES2266554T3 (enExample) |
| IL (2) | IL161545A0 (enExample) |
| MX (1) | MXPA04004673A (enExample) |
| NZ (1) | NZ552216A (enExample) |
| PT (1) | PT1443915E (enExample) |
| TW (1) | TWI297604B (enExample) |
| WO (1) | WO2003043621A1 (enExample) |
| ZA (1) | ZA200403282B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8246969B2 (en) | 2001-11-16 | 2012-08-21 | Skinmedica, Inc. | Compositions containing aromatic aldehydes and their use in treatments |
| WO2004103233A1 (en) * | 2003-05-15 | 2004-12-02 | Cutanix Corporation | Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
| US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
| TW200526678A (en) | 2003-08-01 | 2005-08-16 | Janssen Pharmaceutica Nv | Substituted indole-O-glucosides |
| EP2514756B1 (en) | 2003-08-01 | 2014-12-17 | Mitsubishi Tanabe Pharma Corporation | Novel compounds having inhibitory activity against sodium-dependant glucose transporter |
| WO2007002447A2 (en) * | 2005-06-23 | 2007-01-04 | Bioform Medical, Inc. | Compositions for treating rosacea |
| GB0526283D0 (en) * | 2005-12-23 | 2006-02-01 | Givaudan Sa | Compositions |
| UY30730A1 (es) | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
| HUE035130T2 (en) | 2007-09-10 | 2018-05-02 | Janssen Pharmaceutica Nv | A method for preparing compounds useful as SGLT inhibitors |
| JP5570992B2 (ja) * | 2007-10-10 | 2014-08-13 | セラメティックス エルエルシー | 皮膚病又は皮膚病変の治療方法及び組成物 |
| US9616006B2 (en) | 2007-10-10 | 2017-04-11 | DermaMedics, LLC | Methods and compositions for treating dermatological diseases and conditions |
| CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
| US9056850B2 (en) | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
| US20110009347A1 (en) | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
| EP2488515B1 (en) | 2009-10-14 | 2017-01-04 | Janssen Pharmaceutica NV | Process for the preparation of compounds useful as inhibitors of sglt2 |
| TWI599360B (zh) | 2010-05-11 | 2017-09-21 | 健生藥品公司 | 醫藥調配物 |
| KR101916489B1 (ko) * | 2011-01-07 | 2018-11-07 | 알러간, 인코포레이티드 | 멜라닌 변형 조성물들 및 이의 사용 방법들 |
| RS55056B1 (sr) | 2011-04-13 | 2016-12-30 | Janssen Pharmaceutica Nv | Proces za pripremu jedinjenja koja su korisna kao inhibitori sglt2 |
| TWI542596B (zh) | 2011-05-09 | 2016-07-21 | 健生藥品公司 | （２ｓ,３ｒ,４ｒ,５ｓ,６ｒ）－２－（３－（（５－（４－氟苯基）噻吩－２－基）甲基）－４－甲基苯基）－６－（羥甲基）四氫－２ｈ－哌喃－３,４,５－三醇之ｌ－脯胺酸及檸檬酸共晶體 |
| JP6061373B2 (ja) * | 2012-07-24 | 2017-01-18 | 国立研究開発法人産業技術総合研究所 | ２−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物 |
| CN104473912A (zh) * | 2014-11-26 | 2015-04-01 | 云南中医学院 | 对羟基苯甲醛在制备抗炎药物中的用途 |
| US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
| JP7602855B2 (ja) * | 2017-12-26 | 2024-12-19 | 小林製薬株式会社 | 歯肉組織の破壊抑制剤 |
| FR3081710B1 (fr) * | 2018-05-31 | 2025-03-21 | Bionuclei | Molecule enzymatique mimant une activite antioxydante |
| GB201817785D0 (en) * | 2018-10-31 | 2018-12-19 | Givaudan Sa | Organic compounds |
| WO2022128054A1 (en) * | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (iv) |
| WO2022128051A1 (en) * | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammatory conditions of human skin (ii) |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US414770A (en) * | 1889-11-12 | Swaging-bench for iron fences | ||
| JPS5244375B2 (enExample) * | 1974-04-19 | 1977-11-08 | ||
| DE2519161A1 (de) * | 1975-04-30 | 1976-11-18 | Henkel & Cie Gmbh | Entzuendungshemmer fuer kosmetische praeparationen |
| JPS604801B2 (ja) * | 1977-11-21 | 1985-02-06 | 呉羽化学工業株式会社 | 抗皮膚真菌剤 |
| JPS5545659A (en) * | 1978-09-28 | 1980-03-31 | Rikagaku Kenkyusho | Carcinostatic agent |
| JPS5545656A (en) * | 1978-09-28 | 1980-03-31 | Rikagaku Kenkyusho | Carcinostatic agent |
| JPS5612310A (en) * | 1979-07-10 | 1981-02-06 | Rikagaku Kenkyusho | Carcinostatic agent |
| GB8501646D0 (en) * | 1985-01-23 | 1985-02-27 | Nipa Lab Ltd | Control of micro-organisms |
| US4714609A (en) * | 1986-07-21 | 1987-12-22 | Laverne Stanley | Skin tanning composition |
| JPH085780B2 (ja) * | 1989-04-28 | 1996-01-24 | 呉羽化学工業株式会社 | 変形性関節症治療剤 |
| CA2017923A1 (en) * | 1989-06-06 | 1990-12-06 | Gordon Francis Brunner | Heated oral antitussive compositions |
| GB9026080D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | Pharmaceutical compositions |
| JP3057207B2 (ja) * | 1991-09-03 | 2000-06-26 | 株式会社資生堂 | 皮膚外用剤 |
| US5378468A (en) * | 1992-09-22 | 1995-01-03 | The Mennen Company | Composition containing body activated fragrance for contacting the skin and method of use |
| JPH072640A (ja) * | 1992-10-29 | 1995-01-06 | Marino Forum 21 | 紫外線障害防御外用剤 |
| JPH06329516A (ja) * | 1993-05-21 | 1994-11-29 | Mikimoto Pharmaceut Co Ltd | 化粧料 |
| GB9314929D0 (en) * | 1993-07-19 | 1993-09-01 | Charwell Consumer Prod | Louse repellent compositions |
| JPH07242558A (ja) * | 1994-03-05 | 1995-09-19 | Tomoji Tanaka | 床ズレ防止剤添加体 |
| JP3665360B2 (ja) * | 1994-05-02 | 2005-06-29 | ポーラ化成工業株式会社 | 活性酸素消去剤及びこれを含む組成物 |
| US5614179A (en) * | 1995-09-27 | 1997-03-25 | Church & Dwight Co., Inc. | Cosmetic deodorant products containing a polymer/fragrance-encapsulated bicarbonate ingredient |
| US5733535A (en) * | 1995-10-25 | 1998-03-31 | The Procter & Gamble Co. | Topical compositions containing N-acetylcysteine and odor masking materials |
| US6086903A (en) * | 1996-02-26 | 2000-07-11 | The Proctor & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| US5766575A (en) * | 1996-06-14 | 1998-06-16 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Method and composition for skin lightening |
| US5668182A (en) * | 1996-08-19 | 1997-09-16 | Virginia Commonwealth University | Method of calming or sedating an animal with a hydroxy benzaldehyde compound |
| US6126930A (en) * | 1997-02-13 | 2000-10-03 | The Procter & Gamble Company | Spray compositions |
| ID22656A (id) * | 1997-03-18 | 1999-12-02 | Kao Corp | Komposisi untuk digunakan pada rambut atau kulit |
| US6214879B1 (en) * | 1998-03-24 | 2001-04-10 | Virginia Commonwealth University | Allosteric inhibitors of pyruvate kinase |
| DE19841796A1 (de) * | 1998-09-12 | 2000-03-16 | Beiersdorf Ag | Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden |
| JP2001106639A (ja) * | 1999-10-04 | 2001-04-17 | Taisho Pharmaceut Co Ltd | 経口用組成物 |
-
2002
- 2002-08-16 IL IL16154502A patent/IL161545A0/xx unknown
- 2002-08-16 PT PT02761067T patent/PT1443915E/pt unknown
- 2002-08-16 WO PCT/US2002/021844 patent/WO2003043621A1/en not_active Ceased
- 2002-08-16 AU AU2002326363A patent/AU2002326363B2/en not_active Expired
- 2002-08-16 BR BR0214208-2A patent/BR0214208A/pt not_active IP Right Cessation
- 2002-08-16 EA EA200400689A patent/EA009281B1/ru unknown
- 2002-08-16 JP JP2003545302A patent/JP4587669B2/ja not_active Expired - Lifetime
- 2002-08-16 CN CN2012102290813A patent/CN102973417A/zh active Pending
- 2002-08-16 CA CA2464867A patent/CA2464867C/en not_active Expired - Lifetime
- 2002-08-16 DK DK02761067T patent/DK1443915T3/da active
- 2002-08-16 CN CNA028227166A patent/CN1589136A/zh active Pending
- 2002-08-16 AT AT02761067T patent/ATE330591T1/de active
- 2002-08-16 ES ES02761067T patent/ES2266554T3/es not_active Expired - Lifetime
- 2002-08-16 KR KR1020047007429A patent/KR100887601B1/ko not_active Expired - Fee Related
- 2002-08-16 NZ NZ552216A patent/NZ552216A/en not_active IP Right Cessation
- 2002-08-16 DE DE60212683T patent/DE60212683T2/de not_active Expired - Lifetime
- 2002-08-16 EP EP02761067A patent/EP1443915B1/en not_active Expired - Lifetime
- 2002-08-16 MX MXPA04004673A patent/MXPA04004673A/es active IP Right Grant
- 2002-10-31 TW TW091132250A patent/TWI297604B/zh not_active IP Right Cessation
-
2004
- 2004-04-21 IL IL161545A patent/IL161545A/en active IP Right Grant
- 2004-04-30 ZA ZA200403282A patent/ZA200403282B/en unknown
-
2009
- 2009-12-11 JP JP2009282263A patent/JP2010059203A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005509662A5 (enExample) | ||
| ES2526648T3 (es) | Método para mejorar el estrés oxidativo y la memoria de trabajo mediante la administración de pterostilbeno | |
| JP2024133474A5 (enExample) | ||
| RU98111594A (ru) | Фармацевтические композиции, включающие флурбипрофен | |
| ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
| KR101005715B1 (ko) | 화학적 예방 활성을 나타내는 비스테로이드계 소염제를함유하는 국소 제형 | |
| JP2006514689A5 (ja) | １−オキソ−２−（２，６−ジオキソピペリジン−３−イル）−４−メチルイソインドリンを含む脳腫瘍の治療及び管理のための医薬組成物 | |
| JP2004506682A5 (enExample) | ||
| JP2004517843A5 (enExample) | ||
| JP2005520780A5 (enExample) | ||
| Hay et al. | Short course ketoconazole therapy in pityriasis versicolor | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2020515523A5 (enExample) | ||
| RU98119076A (ru) | Производные 2-(3h)-оксазолона и их применение в качестве ингибиторов сох-2 | |
| Buckley et al. | Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo | |
| JP2002544227A5 (enExample) | ||
| AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
| MXPA05005781A (es) | Combinacion de ibuprofeno y oxicodona para alivio de dolor agudo. | |
| RU2008102911A (ru) | Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы | |
| JP2002534477A5 (enExample) | ||
| JP2002540148A5 (enExample) | ||
| JP4890250B2 (ja) | 火傷した皮膚を治療するための方法及び組成物 | |
| JP2004512376A5 (enExample) | ||
| US5556871A (en) | Method for treating epithelial precancerous lesions with topical inidazoles | |
| JP2004528311A5 (enExample) |